The data revealed no significant correlation between anxiety/depression symptoms and AZA/6-MP resistance, or anti-TNF agents nonresponse, even after adjusting for age, sex, disease severity, and other covariates (Supplementary Table S1). This evidence concerns the gene TNF and depressive symptom measurement.